|
⚲
|
| Orbis Biosciences Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001449477 |
| Sale | 2009-05-06 ($0.2 M Offered, $0.2 M Sold) |
| Fund | |
| Phone | 9135301717 |
| Address | 5426 Central Street Kansas City, 64112 |
| Source | [EDGAR] |
| Fund AUM and Sold ($k) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Bowman Fishback | |
| James Clarke | |
| Cory Berkland |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
Riparian Pharmaceuticals, Inc.
✚
|
0.0 | |
|
RIP Road US Fund LP
✚
|
0.0 | |
|
RIST Neurovascular, Inc.
✚
|
0.0 | |
|
Rivard Ghyslain
✚
|
0.0 | |
|
Rivera Raul
✚
|
0.0 | |
|
Rivercrest Capital Partners LP
✚
|
0.0 | |
|
Freestone Advantage Partners IV LP
✚
|
0.0 | |
|
Freestone Car Wash I LLC
✚
|
0.0 | |
|
Freestyle Fund LLC
✚
|
0.0 | |
|
Rio Two Georgia (No. 1) REIT LLC
✚
|
0.0 |